The New Board Question: “What’s Our Exposure to AI‑Driven Misconduct?”
Two companies, same AI tools, totally different risk profiles. Daniel Santos on the new board question — “What’s our exposure to AI-driven misconduct?” — and why AI accountability, not technology, decides whether your governance holds up under scrutiny.
Red Flag: The Vendor Requested Far More PHI Than the Service Required
A vendor deal that looked routine — clean MSA, sensible pricing, BAA already in place — almost moved forward in minutes. Then the SOW revealed a PHI request far beyond what was actually needed. Robyn D. Marino on why HIPAA compliance doesn’t stop at the BAA, and how SOW-level review changes the risk calculus on healthcare vendor agreements.
“When home.” How a two-word email subject line became part of a $650 million federal case.
By Kevin Brenner | Friday, May 22, 2026 Not Good is not an indictment of…
Do we still need to care about the FCPA?
By: Kevin Brenner, Esquire I’m hearing a surprising version of the same question from clients…
The Fastest Way to Break Compliance? Make Everyone Responsible.
Healthcare compliance accountability is the difference between organizations where compliance moves with the business —…
How One Clause Rewrite Protected Their Data and Future Growth
I worked with a client who nearly signed away something they hadn’t planned to give…
Why Healthcare Investigations Are Really About Revenue, Not Regulation
By Daniel Santos Early in my career, I thought investigations were purely legal exercises. They…
We Caught the Contract Flaw Just Before the CFO Signed
The business was ready to sign the deal. But when we paused to look at…
